Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

T3SS inhibitor MBX-5452 well tolerated and reduces bacterial load in pneumonia mouse model

June 15, 2022

A&J Science synthesizes new antibacterials

June 15, 2022

Q-griffithsin: an antiviral lectin for COVID-19

June 15, 2022

Omadacycline, a promising treatment approach for chlamydial infections

June 14, 2022

Roche discloses new HBV antivirals

June 14, 2022

Teixobactin attenuates anthrax infection in a rabbit model

June 14, 2022

Roche synthesizes new HBV antivirals

June 13, 2022

CyanVac's CVXGA-1 provides broad protection against SARS-CoV-2 strains in hamster model

June 13, 2022

Gepotidacin shows efficacy in nonhuman primate model of pneumonic plague

June 13, 2022

Enanta Pharmaceuticals patents Mpro inhibitors for coronovirus infections

June 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...